Scandinavian Tobacco Group (STG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
21 May, 2026Executive summary
Launched Focus2030 strategy, prioritizing stabilization in machine-rolled cigars, growth in handmade cigars, and expansion in nicotine pouches, with initial execution progressing and market share gains in key segments.
Maintained full-year 2026 financial expectations despite ongoing geopolitical, economic, and regulatory uncertainties.
Investments focused on Power Brands, including Mehari’s rebranding and Cohiba’s new U.S.-made cigar, and cost improvement initiatives.
XQS nicotine pouch brand increased market share in Sweden to 13.6% and partnered with Team Parker Racing for brand visibility.
SAP implementation completed in Europe and Asia, with U.S. rollout planned.
Financial highlights
Q1 2026 net sales were DKK 1,859 million, down 6% year-over-year, with organic net sales down 0.6% due to a 5.2% negative currency effect and delivery timing.
EBITDA before special items was DKK 320 million (+1% year-over-year), with margin improving to 17.2% from 16.1%.
EBIT margin before special items stable at 10.4%, with EBIT at DKK 193 million and a 0.9% negative impact from increased trademark amortization.
Adjusted EPS was DKK 1.1, down from DKK 1.5 in Q1 2025; net profit was DKK 43 million.
Free cash flow before acquisitions was DKK 158 million, supported by positive working capital and recovery of receivables.
Outlook and guidance
2026 guidance maintained: group net sales growth at constant currencies expected between -2% and +2%.
EBIT margin before special items forecasted at 13%-14.5%, down from 14.9% in 2025 due to higher amortization.
Free cash flow before acquisitions projected at DKK 950 million–1.2 billion.
Adjusted EPS expected in the range DKK 9-11.
EBITDA before special items expected to be in line with last year’s DKK 1.8 billion.
Latest events from Scandinavian Tobacco Group
- Organic sales fell 8.8% in Q1 2025, prompting lower guidance amid US and FX headwinds.STG
Q1 202513 Mar 2026 - 2025 results declined, but Focus2030 and strong cash flow support a stable 2026 outlook.STG
Q4 20259 Mar 2026 - Focus2030 targets growth in cigars and nicotine pouches, efficiency, and flexible shareholder returns.STG
CMD 20253 Feb 2026 - Q2 2024 saw 6.3% sales growth, margin gains, and a strategic acquisition for future expansion.STG
Q2 202423 Jan 2026 - Q3 net sales up 7.1% on Mac Baren deal; margin and organic growth declined.STG
Q3 202414 Jan 2026 - Net sales up 5.4% to DKK 9.2bn, but profit down 20.5% amid margin pressure and investments.STG
Q4 202426 Dec 2025 - Record sales, higher dividends, and all board proposals approved amid ongoing strategic investments.STG
AGM 202529 Nov 2025 - Q2 2025 saw flat sales, margin pressure, and guidance reaffirmed despite organic decline.STG
Q2 202523 Nov 2025 - Q3 2025 organic sales rose 0.3% with margin recovery and narrowed full-year guidance.STG
Q3 202512 Nov 2025